Skip to main content

and
  1. No Access

    Article

    The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer

    The DEAD-box RNA helicases p68 (DDX5) and p72 (DDX17) have been shown to act as transcriptional co-activators for a diverse range of transcription factors, including oestrogen receptor-α (ERα). Here, we show t...

    N C Wortham, E Ahamed, S M Nicol, R S Thomas, M Periyasamy, J Jiang in Oncogene (2009)

  2. Article

    Erratum: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF

    Correction to: Gene Therapy (2005) 12, 452–460. doi:10.1038/sj.gt.3302421 The above affiliations for the below authors were published incorrectly, the correct affiliations are given below: N Patel3, S Shousha2...

    L Buluwela, J Pike, D Mazhar, T Kamalati, S M Hart, R Al-Jehani, H Yahaya in Gene Therapy (2005)

  3. Article

    Erratum: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF

    Correction to: Gene Therapy (2005) 12, 452–460. doi:10.1038/sj.gt.3302421 The above author name was published incorrectly, the correct name is given below: N Sarwar The publishers apologise for this error.

    L Buluwela, J Pike, D Mazhar, T Kamalati, S M Hart, R Al-Jehani, H Yahaya in Gene Therapy (2005)

  4. No Access

    Article

    Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF

    Estrogen receptor α (ERα) is a ligand-inducible transcription factor that acts to regulate gene expression by binding to palindromic DNA sequence, known as the estrogen response element, in promoters of estrog...

    L Buluwela, J Pike, D Mazhar, T Kamalati, S M Hart, R Al-Jehani, H Yahaya in Gene Therapy (2005)

  5. Article

    Open Access

    Purified malignant mammary epithelial cells maintain hormone responsiveness in culture

    Currently, the therapy for breast cancer is determined by immunohistochemical staining of the primary tumour for oestrogen receptor alpha (ERα). However, a proportion of ERα-positive patients fail to respond to t...

    M S Kothari, S Ali, L Buluwela, N Livni, S Shousha in British Journal of Cancer (2003)

  6. Article

    Open Access

    Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer

    Fibroblast growth factor 8 can transform NIH3T3 cells and its expression has been found to be associated with breast and prostate cancer. Following our finding that fibroblast growth factor 8 mRNA expression i...

    C Zammit, R Coope, J J Gomm, S Shousha, C L Johnston in British Journal of Cancer (2002)

  7. Article

    Open Access

    Primary tumour characteristics and axillary lymph node status in breast cancer

    This paper examines the correlation between axillary lymph node status and primary tumour characteristics in breast cancer and whether this can be used to select patients for axillary lymphadenectomy. The resu...

    C Yiangou, S Shousha, H D Sinnett in British Journal of Cancer (1999)

  8. No Access

    Article

    Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status

    There is evidence to suggest that breast carcinoma in young women behaves in a more aggressive manner than in older women. As positive immunostaining for p53 has also been associated with increased tumour aggr...

    R. Pratap, S. Shousha in Breast Cancer Research and Treatment (1998)

  9. No Access

    Article

    Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer

    Monoclonal antibodies against two epitopes of FGFR-1 have been used to investigate FGFR-1 expression in the normal and neoplastic human breast. Different forms are detected in the different cell types constitu...

    C Yiangou, H Cox, GS Bansal, R Coope, JJ Gomm, R Barnard in British Journal of Cancer (1997)

  10. No Access

    Article

    The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue

    Acidic fibroblast growth factor (FGF1) and two of its receptors, FGFR1 and FGFR4, were localized in cryostat sections of normal, benign and malignant human breast tissue by immunohistochemistry. Without pretre...

    RC Coope, PJ Browne, C Yiangou, GS Bansal, J Walters, N Groome in British Journal of Cancer (1997)

  11. No Access

    Article

    Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance

    A variant form of the human oestrogen receptor (ER) mRNA lacking sequences encoded within exon 5 has been described (Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malloy BW, McGuir...

    AJ Desai, YA Luqmani, JE Walters, RC Coope, B Dagg, JJ Gomm in British Journal of Cancer (1997)

  12. No Access

    Article

    Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance

    This paper examines the expression of fibroblast growth factor 2 (FGF-2) in the malignant human breast. Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used to assess the level of...

    C Yiangou, JJ Gomm, RC Coope, M Law, YA Luqmani, S Shousha in British Journal of Cancer (1997)

  13. No Access

    Article

    Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients

    We have used polymerase chain reaction (PCR) to measure keratin 19 mRNA in order to detect breast cancer cells invading axillary lymph nodes. In a consecutive series of 125 patients with primary breast cancer,...

    A Schoenfeld, Y Luqmani, HD Sinnett, S Shousha, RC Coombes in British Journal of Cancer (1996)

  14. No Access

    Article

    Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast

    In this study, we used immunohistochemical and biochemical analysis to show that gp200-MR6, a 200 kDa molecule that is functionally associated with the human interleukin 4 (IL-4) receptor complex, is expressed...

    AA AL-Tubuly, YA Luqmani, S Shousha, D Melcher, MA Ritter in British Journal of Cancer (1996)

  15. No Access

    Article

    Oesophageal and gastric carcinoma in the Republic of Yemen

    We conducted a preliminary survey on 3064 patients who underwent upper gastrointestinal endoscopy at the Al-Thawra Hospital in Sana'a, Republic of Yemen, between January and December 1991. The age/sex distribu...

    AA Gunaid, AA Sumairi, RG Shidrawi, A al-Hanaki, M al-Haimi in British Journal of Cancer (1995)

  16. No Access

    Article

    Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast

    The expression of pS2 was examined histochemically in paraffin sections taken from biopsy material from patients diagnosed with ductal carcinoma in situ (DCIS). Often intense immunoreactivity, to an anti-pS2 m...

    YA Luqmani, T Campbell, S Soomro, S Shousha, MC Rio in British Journal of Cancer (1993)

  17. No Access

    Article

    Isolation of a lactoferrin cDNA clone and its expression in human breast cancer

    A cDNA library constructed from mRNA from a human breast carcinoma metastasis was screened with a polyclonal antibody to deglycosylated human milk fat globule membrane, resulting in the isolation of eight clon...

    T Campbell, RA Skilton, RC Coombes, S Shousha, MD Graham in British Journal of Cancer (1992)

  18. No Access

    Chapter

    Histopathology of Breast Carcinoma and Related Conditions

    Carcinoma is a malignant tumor derived from epithelial cells. In the breast, epithelial cell line ducts, and acini or lobules. In these sites malignant transformation is indicated microscopically by the presen...

    S. Shousha in Breast Cancer (1989)

  19. No Access

    Article

    Orcein staining of leukocytes

    An Orcein staining method has been developed which stains mature and immature leukocytes in blood films and bone-marrow smears. Two different patterns of staining are obtained depending on whether staining is ...

    S. Shousha, T. R. Mitchell in The Histochemical Journal (1983)